LeadIQ logo
Learn more at LeadIQ.com

Insights

Rare Disease Designation Solid Biosciences' gene therapy candidate for Duchenne muscular dystrophy received Rare Pediatric Disease Designation from the FDA, opening up sales opportunities in the rare disease segment.

Strategic Partnerships Through partnerships with companies like Armatus Bio, Solid Biosciences is expanding its offerings, presenting cross-selling opportunities for biotechnology solutions in neuromuscular and cardiac diseases.

Key Personnel Expertise Recruitment of experienced professionals like Gabriel Brooks as Chief Medical Officer and Kevin Tan as Chief Financial Officer showcases Solid Biosciences' commitment to expertise, offering opportunities for network collaborations and outreach.

Precision Genetic Therapies Solid Biosciences' collaboration with Phlox to develop precision genetic therapies for rare cardiac diseases presents avenues for targeted marketing and specialized solutions.

Clinical Studies & Trials Solid Biosciences' ongoing clinical studies like the INSPIRE DUCHENNE trial provide channels to engage healthcare providers, researchers, and patients, potentially leading to product adoption and commercialization opportunities.

Similar companies to Solid Biosciences

Solid Biosciences Tech Stack

Solid Biosciences uses 8 technology products and services including Bill.com, MATLAB, Google Analytics, and more. Explore Solid Biosciences's tech stack below.

  • Bill.com
    Accounting And Finance
  • MATLAB
    Advanced Analytics And Data Science
  • Google Analytics
    Analytics
  • Power BI
    Business Intelligence
  • Drupal
    Content Management System
  • ADP Workforce Now
    Human Capital Management
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous

Media & News

Solid Biosciences's Email Address Formats

Solid Biosciences uses at least 1 format(s):
Solid Biosciences Email FormatsExamplePercentage
FLast@solidbio.comJDoe@solidbio.com
69%
First@solidbio.comJohn@solidbio.com
27%
Last@solidbio.comDoe@solidbio.com
2%
First.Last@solidbio.comJohn.Doe@solidbio.com
2%

Frequently Asked Questions

Where is Solid Biosciences's headquarters located?

Minus sign iconPlus sign icon
Solid Biosciences's main headquarters is located at 500 Rutherford Ave Third Floor Boston, Massachusetts 02129 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Solid Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Solid Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Solid Biosciences's stock symbol?

Minus sign iconPlus sign icon
Solid Biosciences is a publicly traded company; the company's stock symbol is SLDB.

What is Solid Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Solid Biosciences's official website is solidbio.com and has social profiles on LinkedIn.

How much revenue does Solid Biosciences generate?

Minus sign iconPlus sign icon
As of September 2024, Solid Biosciences's annual revenue reached $35M.

What is Solid Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Solid Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Solid Biosciences have currently?

Minus sign iconPlus sign icon
As of September 2024, Solid Biosciences has approximately 122 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Technology Officer: P. H.Chief Medical Officer: G. B.Chief Regulatory Officer: J. H.. Explore Solid Biosciences's employee directory with LeadIQ.

What industry does Solid Biosciences belong to?

Minus sign iconPlus sign icon
Solid Biosciences operates in the Biotechnology Research industry.

What technology does Solid Biosciences use?

Minus sign iconPlus sign icon
Solid Biosciences's tech stack includes Bill.comMATLABGoogle AnalyticsPower BIDrupalADP Workforce NowjQueryOpen Graph.

What is Solid Biosciences's email format?

Minus sign iconPlus sign icon
Solid Biosciences's email format typically follows the pattern of . Find more Solid Biosciences email formats with LeadIQ.

How much funding has Solid Biosciences raised to date?

Minus sign iconPlus sign icon
As of September 2024, Solid Biosciences has raised $109M in funding. The last funding round occurred on Jan 08, 2024 for $109M.

When was Solid Biosciences founded?

Minus sign iconPlus sign icon
Solid Biosciences was founded in 2013.
Solid Biosciences

Solid Biosciences

Biotechnology ResearchMassachusetts, United States51-200 Employees

Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients.

Solid is headquartered in Charlestown, MA, USA.

Section iconCompany Overview

Headquarters
500 Rutherford Ave Third Floor Boston, Massachusetts 02129 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SLDB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $109M

    Solid Biosciences has raised a total of $109M of funding over 9 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $109M.

  • $10M$50M

    Solid Biosciences's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $109M

    Solid Biosciences has raised a total of $109M of funding over 9 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $109M.

  • $10M$50M

    Solid Biosciences's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.